News Archive

Displaying 1-10 of 18 results.

Investment in Research & Development

Date Posted: 19/08/2015

Flynn Pharma (Holdings) Ltd is pleased to announce the acquisition of a majority shareholding in MicroPharm Ltd, a privately held company with its headquarters in Wales, UK. MicroPharm’s expertise lies in the production and purification of ov

Helping to build for the future

Date Posted: 30/01/2014

Building for the Future of Disabled Kids Building For The Future (BFTF) is a charity founded in 2007 by a group of parents of disabled children. Their aim was to raise enough money to fund a much-needed community centre for disabled children and their

Flynn Inspires Britain!

Date Posted: 09/12/2013

Flynn Pharma has been recognised by the London Stock Exchange Group in its 1000 Companies to Inspire Britain. The listing highlights SME companies which have shown a positive growth in revenue over the past four years and have generated new, net job cr

MHRA Guidance on the Treatment of Epilepsy

Date Posted: 22/11/2013

Following a review by the Commission on Human Medicines (CHM) the Medicines and Healthcare Products Agency (MHRA) has recently issued new guidance to prescribers, pharmacists and patients in relation to anti-epileptic drugs (AEDs). CHM conclu

A short history of vancomycin

Date Posted: 01/08/2013

Vancomycin was initially isolated by E.C. Kornfeld (operating at Eli Lilly) from a sample of soil acquired from the heart of the jungles in Borneo by a missionary. The organism that created it was in time named Streptomyces orientalis. To begin with the i

Innovators

Date Posted: 02/07/2013

Flynn Pharma has proven itself to be an innovator over the recent months. It has introduced 'Augmented Reality' technology into its latest patient information leaflets. This means that when a mobile device is hovered over the leaflet, additio

Important: For Wholesalers and Pharmacists

Date Posted: 12/12/2012

Re:Phenytoin Sodium Flynn 300mg Hard Capsules In order to help mitigate the risk of an out of stock situation for Phenytoin Sodium Flynn 300mg Hard Capsules, Flynn Pharma secured MHRA agreement to over-label a limited quantity of blister strips packed

Changes to the prescribing and availability of Epanutin (Phenytoin Sodium) capsules

Date Posted: 30/09/2012

Summary: Epanutin Capsules are to be discontinued. All other presentations of Epanutin™ continue to be available from Pfizer. Phenytoin Sodium Flynn Hard Capsules are available. Patient freephone helpline, 0800 077 8566, available to help

Depodur marketing ceased

Date Posted: 30/06/2012

At the end of June 2012 Flynn Pharma ceased the marketing of Depodur after 3 successful years. Depodur was the only Extended-Release Epidural Opioid for Post-Operative Pain, in the UK. It was distributed through Flynn’s specialist hospital division.

Black Triangle Removal

Date Posted: 08/06/2012

The Medicines and Healthcare products Regulatory Agency (MHRA) has reviewed the benefits and risks associated with Circadin and has confirmed that from Friday 3rd August 2012, there will no longer be a requirement for this product to show a black tri

Call us on

+44 (0)1438 727 822

Email Us

office2@flynnpharma.com

About Us

News Archive

Call us on

Email Us

Enquire Online